Literature DB >> 21393564

Reversals of association for Pap, colorectal, and prostate cancer testing among Hispanic and non-Hispanic black women and men.

William Rakowski1, Melissa A Clark, Michelle L Rogers, Sherry H Weitzen.   

Abstract

BACKGROUND: Several studies have found that Hispanics and non-Hispanic blacks have statistically significantly higher adjusted OR for cancer screening tests compared to non-Hispanic whites, even though their crude percentages were lower than, or about equal to, those for the non-Hispanic whites. Most documentation is for mammography. This article investigates the prevalence of such unadjusted-to-adjusted "reversed associations" (RA) for Pap, colorectal, and prostate testing. We also investigate large percent changes (LPC) to the unadjusted ORs.
METHODS: Data were from the 2004/2006/2008 Behavioral Risk Factor Surveillance System (BRFSS) and the 2000/2003/2005/2008 National Health Interview Survey (NHIS). Analyses used a consistent set of covariates.
RESULTS: RAs were more common for non-Hispanic blacks than Hispanics, but Hispanics had a greater number of LPCs. RAs and LPCs occurred more often for Pap testing than colorectal and prostate testing. However, results from the BRFSS and NHIS were often not consistent.
CONCLUSIONS: Attention should be given to the National Breast and Cervical Cancer Early Detection Program, as well as public programs addressing other cancers, as possible contributors to RAs and LPCs. Hispanics may show more RAs in analyses of future data. Discrepancies between the BRFSS and the NHIS also must be recognized and explained. IMPACT: This research highlights the need for vigilance regarding the results of analyses to identify race/ethnicity as a correlate of cancer screening. Results also direct attention to aspects of the results of multivariable analysis other than ORs and confidence intervals. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21393564      PMCID: PMC3089667          DOI: 10.1158/1055-9965.EPI-10-1226

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  National Health Interview Survey: research for the 1995-2004 redesign.

Authors: 
Journal:  Vital Health Stat 2       Date:  1999-07

Review 2.  Cancer screening practices from National Health Interview Surveys: past, present, and future.

Authors:  Robert A Hiatt; Carrie Klabunde; Nancy Breen; Judith Swan; Rachel Ballard-Barbash
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

3.  Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team.

Authors:  Ali H Mokdad; Donna F Stroup; Wayne H Giles
Journal:  MMWR Recomm Rep       Date:  2003-05-23

4.  Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.

Authors:  Sujha Subramanian; Mayur M Amonkar; Timothy L Hunt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

5.  Pap smear use in California: are we closing the racial/ethnic gap?

Authors:  Israel De Alba; Quyen Ngo-Metzger; Jamie M Sweningson; F Allan Hubbell
Journal:  Prev Med       Date:  2005-06       Impact factor: 4.018

6.  Associations in breast and colon cancer screening behavior in women.

Authors:  Ruth C Carlos; A Mark Fendrick; Stephanie K Patterson; Steven J Bernstein
Journal:  Acad Radiol       Date:  2005-04       Impact factor: 3.173

Review 7.  Perspectives on behavioral and social science research on cancer screening.

Authors:  William Rakowski; Erica S Breslau
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD).

Authors:  Truls Ostbye; Gary N Greenberg; Donald H Taylor; Ann Marie M Lee
Journal:  Ann Fam Med       Date:  2003 Nov-Dec       Impact factor: 5.166

9.  Start-up of the colorectal cancer screening demonstration program.

Authors:  Amy DeGroff; Debra Holden; Sonya Goode Green; Jennifer Boehm; Laura C Seeff; Florence Tangka
Journal:  Prev Chronic Dis       Date:  2008-03-15       Impact factor: 2.830

10.  Facilitators and challenges to start-up of the colorectal cancer screening demonstration program.

Authors:  Amy DeGroff; Jennifer Boehm; Sonya Goode Green; Debra Holden; Laura C Seeff
Journal:  Prev Chronic Dis       Date:  2008-03-15       Impact factor: 2.830

View more
  5 in total

1.  Clinical quality performance in U.S. health centers.

Authors:  Leiyu Shi; Lydie A Lebrun; Jinsheng Zhu; Arthur S Hayashi; Ravi Sharma; Charles A Daly; Alek Sripipatana; Quyen Ngo-Metzger
Journal:  Health Serv Res       Date:  2012-05-17       Impact factor: 3.402

2.  Understanding reversals of association between cancer screening and race/ethnicity.

Authors:  William Rakowski; Michelle L Rogers; Gregory M Dominick; Melissa A Clark
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-26       Impact factor: 4.254

3.  Editor's Choice: Deliberative and non-deliberative effects of descriptive and injunctive norms on cancer screening behaviors among African Americans.

Authors:  Mark Manning; Todd Lucas; Stacy N Davis; Heiddis B Valdimarsdottir; Hayley Thompson
Journal:  Psychol Health       Date:  2019-11-20

4.  Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.

Authors:  Jacqueline M Hirth; Tabassum Haque Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  J Womens Health (Larchmt)       Date:  2015-11-18       Impact factor: 2.681

Review 5.  Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors.

Authors:  Jada G Hamilton; Nancy Breen; Carrie N Klabunde; Richard P Moser; Bryan Leyva; Erica S Breslau; Sarah C Kobrin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-09       Impact factor: 4.254

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.